{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:55:26Z","timestamp":1788260126951,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13256-017-1384-2","type":"journal-article","created":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T14:55:37Z","timestamp":1501512937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report"],"prefix":"10.1186","volume":"11","author":[{"given":"Ibrahim","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonu","family":"Nigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Parnham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay","family":"Srinivasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,6]]},"reference":[{"issue":"14","key":"1384_CR1","doi-asserted-by":"crossref","first-page":"4466","DOI":"10.1021\/jm900431g","volume":"52","author":"GJ Roth","year":"2009","unstructured":"Roth GJ, Heckel A, Colbatzky F, Handschuh S, Kley J, Lehmann-Lintz T, et al. Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120). J Med Chem. 2009;52(14):4466\u201380.","journal-title":"J Med Chem"},{"issue":"9","key":"1384_CR2","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1016\/j.humpath.2014.05.015","volume":"45","author":"J Usui","year":"2014","unstructured":"Usui J, Glezerman IG, Salvatore SP, Chandran CB, Flombaum CD, Seshan SV. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature. Hum Pathol. 2014;45(9):1918\u201327.","journal-title":"Hum Pathol"},{"issue":"3","key":"1384_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00041552-200205000-00003","volume":"11","author":"AD Salama","year":"2002","unstructured":"Salama AD, Pusey CD. Immunology of anti-glomerular basement membrane disease. Curr Opin Nephrol Hypertens. 2002;11(3):279\u201386.","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"1384_CR4","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/ckj\/sfv008","volume":"8","author":"GHB Greenhall","year":"2015","unstructured":"Greenhall GHB, Salama AD. What is new in the management of rapidly progressive glomerulonephritis? Clin Kidney J. 2015;8(2):143\u201350.","journal-title":"Clin Kidney J"},{"issue":"6","key":"1384_CR5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1159\/000166666","volume":"2","author":"IJ Simpson","year":"1982","unstructured":"Simpson IJ, Doak PB, Williams LC, Blacklock HA, Hill RS, Teague CA, et al. Plasma exchange in Goodpasture\u2019s syndrome. Am J Nephrol. 1982;2(6):301\u201311.","journal-title":"Am J Nephrol"},{"issue":"2","key":"1384_CR6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000180389","volume":"13","author":"GO Perez","year":"1974","unstructured":"Perez GO, Bjornsson S, Ross AH, Aamato J, Rothfield N. A mini-epidemic of Goodpasture\u2019s syndrome clinical and immunological studies. Nephron. 1974;13(2):161\u201373.","journal-title":"Nephron"},{"issue":"5","key":"1384_CR7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00005792-197709000-00001","volume":"56","author":"GJ Beirne","year":"1977","unstructured":"Beirne GJ, Wagnild JP, Zimmerman SW, Macken PD, Burkholder PM. Idiopathic crescentic glomerulonephritis. Medicine (Baltimore). 1977;56(5):349\u201381.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1384_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ajim.4700210204","volume":"21","author":"GJ Bombassei","year":"1992","unstructured":"Bombassei GJ, Kaplan AA. The association between hydrocarbon exposure and anti-glomerular basement membrane antibody-mediated disease (Goodpasture\u2019s syndrome). Am J Ind Med. 1992;21(2):141\u201353.","journal-title":"Am J Ind Med"},{"issue":"7","key":"1384_CR9","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1681\/ASN.V271227","volume":"2","author":"MF Weber","year":"1992","unstructured":"Weber MF, Andrassy K, Pullig O, Koderisch J, Netzer K. Antineutrophil-cytoplasmic antibodies and antiglomerular basement membrane antibodies in Goodpasture\u2019s syndrome and in Wegener\u2019s granulomatosis. J Am Soc Nephrol. 1992;2(7):1227\u201334.","journal-title":"J Am Soc Nephrol"},{"issue":"8693","key":"1384_CR10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/0140-6736(90)90971-7","volume":"335","author":"V Guerin","year":"1990","unstructured":"Guerin V, Rabian C, Noel LH, Droz D, Baron C, Lallemand F, et al. Anti-glomerular-basement-membrane disease after lithotripsy. Lancet. 1990;335(8693):856\u20137.","journal-title":"Lancet"},{"issue":"8844","key":"1384_CR11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0140-6736(93)90316-9","volume":"341","author":"T Umekawa","year":"1993","unstructured":"Umekawa T, Kohri K, Iguchi M, Yoshioka K, Kurita T. Glomerular-basement-membrane antibody and extracorporeal shock wave lithotripsy. Lancet. 1993;341(8844):556.","journal-title":"Lancet"},{"issue":"1","key":"1384_CR12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0272-6386(99)70268-4","volume":"33","author":"A Xenocostas","year":"1999","unstructured":"Xenocostas A, Jothy S, Collins B, Loertscher R, Levy M. Anti-glomerular basement membrane glomerulonephritis after extracorporeal shock wave lithotripsy. Am J Kidney Dis. 1999;33(1):128\u201332.","journal-title":"Am J Kidney Dis"},{"issue":"8364","key":"1384_CR13","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/S0140-6736(83)90923-6","volume":"2","author":"M Donaghy","year":"1983","unstructured":"Donaghy M, Rees AJ. Cigarette smoking and lung haemorrhage in glomerulonephritis caused by autoantibodies to glomerular basement membrane. Lancet. 1983;2(8364):1390\u20133.","journal-title":"Lancet"},{"issue":"24","key":"1384_CR14","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJM197406132902403","volume":"290","author":"J Klassen","year":"1974","unstructured":"Klassen J, Elwood C, Grossberg AL, Milgrom F, Montes M, Sepulveda M, et al. Evolution of membranous nephropathy into anti-glomerular-basement-membrane glomerulonephritis. N Engl J Med. 1974;290(24):1340\u20134.","journal-title":"N Engl J Med"},{"issue":"1","key":"1384_CR15","first-page":"319","volume":"6","author":"AV Moorthy","year":"1976","unstructured":"Moorthy AV, Zimmerman SW, Burkholder PM, Harrington AR. Association of crescentic glomerulonephritis with membranous glomerulonephropathy: a report of three cases. Clin Nephrol. 1976;6(1):319\u201325.","journal-title":"Clin Nephrol"},{"issue":"2","key":"1384_CR16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10157-010-0390-0","volume":"15","author":"K Nakabayashi","year":"2011","unstructured":"Nakabayashi K, Fujioka Y, Nagasawa T, Kimura T, Kojima K, Arimura Y, et al. Dual myeloperoxidase-antineutrophil cytoplasmic antibody- and antiglomerular basement membrane antibody-positive cases associated with prior pulmonary fibrosis: a report of four cases. Clin Exp Nephrol. 2011;15(2):226\u201334.","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"1384_CR17","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","volume":"192","author":"G Raghu","year":"2015","unstructured":"Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, et al. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192(2):e3\u201319.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"1384_CR18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.rmed.2014.04.011","volume":"108","author":"L Richeldi","year":"2014","unstructured":"Richeldi L, Cottin V, Flaherty KR, Kolb M, Inoue Y, Raghu G, et al. Design of the INPULSIS trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis. Respir Med. 2014;108(7):1023\u201330.","journal-title":"Respir Med"},{"issue":"Suppl 9","key":"1384_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/ndt\/17.suppl_9.25","volume":"17","author":"Y Kitamoto","year":"2002","unstructured":"Kitamoto Y, Tokunaga H, Miyamoto K, Tomita K. VEGF is an essential molecule for glomerular structuring. Nephrol Dial Transplant. 2002;17 Suppl 9:25\u20137.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1384_CR20","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/j.1523-1755.2004.00621.x","volume":"65","author":"BF Schrijvers","year":"2004","unstructured":"Schrijvers BF, Flyvbjerg A, De Vriese AS. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004;65(6):2003\u201317.","journal-title":"Kidney Int"},{"issue":"6","key":"1384_CR21","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1681\/ASN.2010101049","volume":"22","author":"K Sharma","year":"2011","unstructured":"Sharma K, Ix JH, Mathew AV, Cho M, Pflueger A, Dunn SR, et al. Pirfenidone for diabetic nephropathy. J Am Soc Nephrol. 2011;22(6):1144\u201351.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1384_CR22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1755-1536-3-16","volume":"3","author":"J Mac\u00edas-Barrag\u00e1n","year":"2010","unstructured":"Mac\u00edas-Barrag\u00e1n J, Sandoval-Rodr\u00edguez A, Navarro-Partida J, Armend\u00e1riz-Borunda J. The multifaceted role of pirfenidone and its novel targets. Fibrogenesis Tissue Repair. 2010;3(1):16.","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"11","key":"1384_CR23","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1097\/01.LAB.0000096711.58115.46","volume":"83","author":"K Kanemoto","year":"2003","unstructured":"Kanemoto K, Usui J, Tomari S, Yokoi H, Mukoyama M, Aten J, et al. Connective tissue growth factor participates in scar formation of crescentic glomerulonephritis. Lab Invest. 2003;83(11):1615\u201325.","journal-title":"Lab Invest"},{"issue":"1","key":"1384_CR24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/ki.1993.15","volume":"43","author":"NA Kefalides","year":"1993","unstructured":"Kefalides NA, Ohno N, Wilson CB. Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen. Kidney Int. 1993;43(1):85\u201393.","journal-title":"Kidney Int"},{"issue":"4","key":"1384_CR25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1056\/NEJMoa0910500","volume":"363","author":"V Pedchenko","year":"2010","unstructured":"Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010;363(4):343\u201354.","journal-title":"N Engl J Med"},{"issue":"2","key":"1384_CR26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1440-1797.2011.01511.x","volume":"17","author":"XY Jia","year":"2012","unstructured":"Jia XY, Qu Z, Cui Z, Yang R, Zhao J, Zhao MH. Circulating anti-glomerular basement membrane autoantibodies against alpha3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays. Nephrology (Carlton). 2012;17(2):160\u20136.","journal-title":"Nephrology (Carlton)"},{"issue":"22","key":"1384_CR27","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.291.22.2720","volume":"291","author":"VH Murthy","year":"2004","unstructured":"Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291(22):2720\u20136.","journal-title":"JAMA"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-017-1384-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,31]],"date-time":"2022-07-31T17:02:37Z","timestamp":1659286957000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-017-1384-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,6]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1186\/s13256-017-1384-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,6]]},"article-number":"214"}}